Home LiteratureArticle Details
PMID: 1383147 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Differential effects of monoclonal antibodies to tumor necrosis factor alpha and gamma interferon on induction of hepatic nitric oxide synthase in experimental gram-negative sepsis.

Infection and immunity ·Vol. 60 ·No. 10 ·1992-10-00 ·Pages 4133-9

Evans T, Carpenter A, Silva A, Cohen J

Abstract

To investigate the stimuli required for the induction of nitric oxide synthase (NOS) in sepsis, we have analyzed the levels of this enzyme in the livers of mice infected with a 90% lethal dose of Escherichia coli in a model of gram-negative sepsis. Hepatic NOS levels are markedly induced in this model, with peak values occurring 12 to 22 h following infection. Treatment with TN3-19.12, a neutralizing monoclonal antibody to tumor necrosis factor alpha (TNF-alpha), resulted in complete protection from death in this model of sepsis but had no significant effect on the level of induction of hepatic NOS. Treatment with H22, a monoclonal antibody to gamma interferon (IFN-gamma), also gave significant protection against death and, in addition, did lead to a decrease in the level of induction of the hepatic NOS. Treatment of mice with pure TNF-alpha (0.2 microgram), IFN-gamma (2,000 U), or a combination of the two did not induce the hepatic NOS, but treatment with the combination led to significant mortality (probability of survival at 22 h, 0.32). Thus, the level of induction of NOS within the liver either in sepsis or by the coadministration of TNF-alpha and IFN-gamma does not correlate with death.

MeSH Terms
Amino Acid Oxidoreductases/analysis,biosynthesis Animals Antibodies, Monoclonal/immunology Enzyme Induction Gram-Negative Bacterial Infections/enzymology Interferon-gamma/physiology Liver/enzymology Male Mice Nitric Oxide Synthase Tumor Necrosis Factor-alpha/analysis,physiology
Chemicals
Antibodies, Monoclonal Tumor Necrosis Factor-alpha Interferon-gamma Nitric Oxide Synthase Amino Acid Oxidoreductases
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Evans T
Department of Infectious Diseases and Bacteriology, Royal Postgraduate Medical School, London, United Kingdom.
Carpenter A
Silva A
Cohen J
References (36)
36 references, click to expand
  1. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock.
    Nature. 1990 Dec 6;348(6301):550-2 PMID: 2147233
  2. Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis.
    Ann Surg. 1990 Oct;212(4):462-9; discussion 470-1 PMID: 2121110
  3. NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide.
    Proc Natl Acad Sci U S A. 1990 May;87(9):3629-32 PMID: 2333306
  4. Inducible cytosolic enzyme activity for the production of nitrogen oxides from L-arginine in hepatocytes.
    Biochem Biophys Res Commun. 1990 May 16;168(3):1034-40 PMID: 2346476
  5. Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-alpha in experimental gram-negative shock.
    J Infect Dis. 1990 Aug;162(2):421-7 PMID: 2373872
  6. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors.
    J Immunol. 1989 Jun 1;142(11):3884-93 PMID: 2469726
  7. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum.
    Proc Natl Acad Sci U S A. 1989 Nov;86(22):9030-3 PMID: 2573074
  8. Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity.
    J Immunol. 1985 Mar;134(3):1609-18 PMID: 2578513
  9. An L-arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro.
    J Exp Med. 1989 Apr 1;169(4):1467-72 PMID: 2926330
  10. Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitors.
    Am J Pathol. 1987 Sep;128(3):410-25 PMID: 3115109
  11. Cytokine appearance in human endotoxemia and primate bacteremia.
    Surg Gynecol Obstet. 1988 Feb;166(2):147-53 PMID: 3122336
  12. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.
    J Immunol. 1988 Oct 1;141(7):2407-12 PMID: 3139757
  13. Shock and tissue injury induced by recombinant human cachectin.
    Science. 1986 Oct 24;234(4775):470-4 PMID: 3764421
  14. Purification of a distinctive form of endotoxin-induced nitric oxide synthase from rat liver.
    Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5361-5 PMID: 1376917
  15. Differential induction of brain, lung and liver nitric oxide synthase by endotoxin in the rat.
    Biochem J. 1990 Sep 15;270(3):833-6 PMID: 1700698
  16. Nitric oxide: physiology, pathophysiology, and pharmacology.
    Pharmacol Rev. 1991 Jun;43(2):109-42 PMID: 1852778
  17. Pathophysiology and treatment of septic shock.
    JAMA. 1991 Jul 24-31;266(4):548-54 PMID: 2061983
  18. The role of IFN-gamma in the pathology of experimental endotoxemia.
    J Immunol. 1990 Nov 1;145(9):2920-4 PMID: 2120341
  19. Monoclonal antibody to endotoxin core protects mice from Escherichia coli sepsis by a mechanism independent of tumor necrosis factor and interleukin-6.
    J Infect Dis. 1990 Aug;162(2):454-9 PMID: 2197338
  20. Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrate/nitrate biosynthesis while promoting hepatic damage.
    J Leukoc Biol. 1990 Dec;48(6):565-9 PMID: 2230601
  21. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine.
    J Immunol. 1990 Jun 15;144(12):4794-7 PMID: 2351828
  22. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells.
    J Immunol. 1987 Jan 15;138(2):550-65 PMID: 2432129
  23. Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells.
    J Exp Med. 1989 Nov 1;170(5):1769-74 PMID: 2509627
  24. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease.
    Lancet. 1987 Feb 14;1(8529):355-7 PMID: 2880163
  25. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma.
    J Immunol. 1987 Jul 15;139(2):518-25 PMID: 3110273
  26. Induction of tumor necrosis factor, IFN-gamma, and acute lethality in mice by toxic and non-toxic forms of lipid A.
    J Immunol. 1988 Aug 1;141(3):870-4 PMID: 3135314
  27. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.
    Nature. 1987 Dec 17-23;330(6149):662-4 PMID: 3317066
  28. Observations on the measurement and evaluation of endotoxemia by a quantitative limulus lysate microassay.
    J Infect Dis. 1984 Dec;150(6):916-24 PMID: 6501933
  29. Protective and pathological roles of nitric oxide in endotoxin shock.
    Cardiovasc Res. 1992 Jan;26(1):48-57 PMID: 1516112
  30. Septic shock: pathogenesis.
    Lancet. 1991 Sep 21;338(8769):732-6 PMID: 1679876
  31. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial?
    Lancet. 1991 Dec 21-28;338(8782-8783):1555-7 PMID: 1683974
  32. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells.
    FEBS Lett. 1990 Nov 26;275(1-2):87-90 PMID: 1702067
  33. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock.
    Lancet. 1991 Dec 21-28;338(8782-8783):1557-8 PMID: 1720856
  34. Monoclonal antibody to TNF in severe septic shock.
    Lancet. 1990 May 26;335(8700):1275-7 PMID: 1971339
  35. Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin.
    J Natl Cancer Inst. 1990 May 2;82(9):772-6 PMID: 2109093
  36. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo.
    Eur J Pharmacol. 1990 Jul 17;182(3):591-5 PMID: 2226626
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1992-10-00
Pages
4133-9
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC257445
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]